A new study looked at the benefits when clinicians counsel patients on their physical activity – and how routine assessments lower the risk of conditions like cancer, diabetes and heart disease.
Nicotinamide Riboside Effective in Relieving Peripheral Neuropathy Induced by a Common Anticancer Agent
Findings of a recent study published in PAIN demonstrated what may lead to reductions in the neuropathic pain experienced by millions of patients suffering from neuropathy.
Doctors and patients should be aware of early warning signs for pancreatic cancer in people with diabetes, which has links to diabetes medications.
Americans now take obesity as seriously as cancer, and say it’s an even bigger health threat than heart disease, the nation’s leading killer.
Six Latin American and Caribbean countries continue to face challenges managing more complex health needs related to certain diseases and conditions.
Study determines that diabetes, coexisting with solid-organ malignancies, is associated with risk of hospitalization and multiple hospitalizations.
Heartland Food Products Group, makers of Splenda Sweeteners, is claiming that the recent CSPI rating on Sucralose is misleading to consumers.
The Center for Science in the Public Interest has downgraded it’s safety rating of the artificial sweetener sucralose for the second time in 3 years due to possible health risk. This is in response to a recently published study by an independent laboratory.
Researchers at Massachusetts General Hospital may have uncovered a novel mechanism behind the ability of the diabetes drug metformin to inhibit the progression of pancreatic cancer.
A scientific statement on endocrine-disrupting chemicals finds that they are so common that nearly every person on Earth has been exposed.